, Ainsi il est crucial d'identifier ces engagements et puis essayer d'être innovant tout en les considérants. De plus, il y a un grand besoin ; celui de l'engagement de la part du management sur des stratégies d'innovation. Sans quoi, rien n'avancera vraiment. Les personnes peuvent être divisées en plusieurs catégories
The Digital Revolution: What's on the Horizon, IT Professional, vol.16, issue.1, pp.8-12, 2014. ,
Towards a Hyper-Connected World, 2012. ,
Toute résistance est inutile, vous serez assimilés ! »-Claude Molly-Mitton USF, 2015. ,
« Health Care 2020: Reengineering Health Care Delivery to Combat Chronic Disease, The American Journal of Medicine, vol.128, issue.4, pp.337-380, 2015. ,
, New Paradigms in Telemedicine: Ambient Intelligence, Wearable, Pervasive and Personalized, vol.108, pp.123-155, 2005.
,
, « Recent trends and future of pharmaceutical packaging technology, Journal of Pharmacy & Bioallied Sciences, vol.5, issue.2, pp.98-110, 2013.
, Critical Care Medicine, vol.37, pp.50-58, 2009.
« From R&D to RID: Design strategies and the management of innovation fields ,
Complémentarité des processus, analyse comparative des mécanismes de diffusion. Cécile Ayerbe-machat-XIIème conférence de l'association Internationale de Management stratégique, 2003. ,
, Global Health Observatory-World Health Statistic, 2014.
« Potential Malaria Outbreak in Germany due to Climate Warming: Risk Modelling Based on Temperature Measurements and Regional Climate Models ». Environmental Science and Pollution Research International 18, pp.428-463, 2011. ,
« Some Perspectives on Affordable Healthcare Systems in China, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, p.6155, 2007. ,
« Patient Education and Self-Management Programs in Arthritis », Medical Journal of Australia, vol.180, pp.23-26, 2004. ,
Biologicals and biosimilars: a review of the science and its implications, Generics and Biosimilars Initiative Journal (GaBI J), vol.1, issue.1, pp.13-19, 2012. ,
, Challenges with Advanced Therapy Medicinal Products and How to Meet Them, vol.9, pp.195-201, 2010.
, Progress towards the "Golden Age" of Biotechnology, vol.24, pp.6-13, 2013.
Rapport de synthèse-Bioproduction, Etat des lieux et recommendation pour l'attractivité de la France-Leem Biotech & Genolpole / Developpement et conseil, 2008. ,
« Failure of SCID-X1 Gene Therapy in Older Patients, Blood, vol.105, issue.11, pp.4255-57 ,
« Gene Therapy for Severe Combined Immunodeficiency: Are We There Yet?, The Journal of Clinical Investigation, vol.117, issue.6, pp.1456-65, 2007. ,
Adipogenic Differentiation of Human Induced Pluripotent Stem Cells: Comparison with that of Human Embryonic Stem Cells, FEBS Letters, vol.583, issue.6, pp.1029-1062 ,
Première mondiale: Des cellules au secours du coeur »-Le monde ,
, Transparency Committee Opinion, Chondrocelect"-HAS, vol.29, 2013.
« IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity », Nature, vol.410, pp.1107-1118, 2001. ,
« Hierarchical Clustering of Immunohistochemical Analysis of the Activated ErbB/PI3K/Akt/NF-kappaB Signalling Pathway and Prognostic Significance in Prostate Cancer, British Journal of Cancer, vol.102, issue.7, pp.1163-73 ,
Le marché des dispositifs médicaux »-Agence d'intelligence économique, 2011. ,
, UV-sensor, minimize sun damage and track sun-generated vitamin D
DNA Nanorobot developed for future immune responses programming, Medgadget.com, 2012. ,
« Polypeptide Nanocoatings for Preventing Dental and Orthopaedic Device-Associated Infection: pH-Induced Antibiotic Capture, Release, and Antibiotic Efficacy, Journal of Biomedical Materials Research. Part B, Applied Biomaterials, vol.88, issue.2, pp.332-370, 2009. ,
« Nanotechnology Tools for Single-Virus Particle Detection, Indian Journal of Medical Microbiology, vol.28, issue.2, pp.95-99, 2010. ,
Consolación Melguizo, et Antonia Aranega. « Nanomedicine: Application Areas and Development Prospects, International Journal of Molecular Sciences, vol.12, issue.5, pp.3303-3324, 2011. ,
Principles of Regenerative Medicine, pp.733-1105, 2011. ,
« Use and Application of Gelatin as Potential Biodegradable Packaging Materials for Food Products, International Journal of Biological Macromolecules, vol.71, pp.94-102, 2014. ,
, Theranostics: A combination of diagnostics and therapy
, Jérôme Topsent | Galderma R&D-Year, 201566.
« Actual concept of "probiotics": Is it more functional to science or business?, World Journal of Gastroenterology : WJG, vol.19, issue.10 ,
« Skin Microbiome: Looking back to Move Forward, The Journal of Investigative Dermatology, vol.132, issue.2, pp.933-972, 2012. ,
, Acne Vulgaris, Probiotics and the Gut-Brain-Skin Axis: From Anecdote to Translational Medicine, vol.5, pp.185-99
Cosmetic drug or cosmeceutical-What is the difference ,
« Traditional Uses and Potential Health Benefits of, Journal of Ethnopharmacology, vol.128, issue.2, pp.268-78 ,
« Models for Open Innovation in the Pharmaceutical Industry. » Drug Discovery Today 18, pp.1133-1170, 2013. ,
, Philippes Iberzahn, analyse du live « Immunity to change
, Juillet, 2015.
« From R&D to RID », 8th IPDM conference, 2001. ,
, Faut-il encore investor en R&D
, The Evolution of Open Innovation: An Interview with Henry Chesbrough :: Open Innovation Community
Open Innovation: The New Imperative for Creating and Profiting from Technology, 2003. ,
, Jérôme Topsent | Galderma R&D-Year, 2015.
, Antibody-Nature images
,
, Code-Source: Google bank of images-Free label for use consulted the
, Vision tools & Google glass-Source: Google bank of images-Free label
, In a context of digital (r)evolution and hyperconnectivity, where is innovation in healthcare?
, Jérôme Topsent | Galderma R&D-Year, 2015.
, Filler of tomorrow-Source: Google bank of images-Free label for use consulted the